Ashleigh Doherty

Ashleigh Doherty is an experienced professional in the pharmaceutical and environmental sectors, currently serving as an MSAT specialist in cell culture at Alexion Pharmaceuticals, Inc. since October 2023. Prior to this role, Ashleigh worked at Bristol-Myers Squibb as a Bioprocess Associate in upstream processes from March 2018 to November 2023. Earlier experience includes serving as a Laboratory Analyst at TMS Environment Ltd from June 2016 to March 2018, providing accredited laboratory testing services in line with ISO 17025 standards. Educational qualifications include a Master of Science in Cancer and Therapeutics from Queen Mary University of London and a Bachelor of Science in Analytical Science from Dublin City University.